menu
    • menu

    Company profile for BeOne Medicines

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BeOne Medicines, based in Switzerland, is a global oncology company dedicated to discovering and developing innovative, affordable cancer treatments. Its portfolio covers both hematology and solid tumors, and it advances its diverse pipeline through strong in-house expertise and strategic collaborations. With over 11,000 employees across six continents, BeOne is driven by a mission to significantly expand access to life-changi...
    BeOne Medicines, based in Switzerland, is a global oncology company dedicated to discovering and developing innovative, affordable cancer treatments. Its portfolio covers both hematology and solid tumors, and it advances its diverse pipeline through strong in-house expertise and strategic collaborations. With over 11,000 employees across six continents, BeOne is driven by a mission to significantly expand access to life-changing medicines for cancer patients worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BeOne MedicinesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cambridge, Massachusetts
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://beonemedicines.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/beonemedicines/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Beonemedicines

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Grants Priority Review To Sonrotoclax
    FDA Grants Priority Review To Sonrotoclax

    26 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251126490630/en/U.S.-FDA-Grants-Priority-Review-to-Sonrotoclax-for-the-Treatment-of-Relapsed-or-Refractory-Mantle-Cell-Lymphoma

    BUSINESSWIRE
    26 Nov 2025
    Share Share
    Beone Medicines Highlights B-Cell Malignancy Leadership At ASH
    Beone Medicines Highlights B-Cell Malignancy Leadership At ASH

    20 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251120303213/en/BeOne-Medicines-Showcases-Leadership-in-B-cell-Malignancies-at-ASH-2025

    BUSINESSWIRE
    20 Nov 2025
    Share Share
    Positive Ph3 Data Support ZIIHERA as HER2 Therapy-of-Choice
    Positive Ph3 Data Support ZIIHERA as HER2 Therapy-of-Choice

    17 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251117406992/en/Positive-Phase-3-Results-Support-ZIIHERA-as-HER2-Targeted-Therapy-of-Choice-and-Combination-with-TEVIMBRA-and-Chemotherapy-as-New-Standard-of-Care-in-First-Line-HER2-Positive-Locally-Advanced-or-Metastatic-Gastroesophageal-Adenocarcinoma

    BUSINESSWIRE
    17 Nov 2025
    Share Share
    BeOne Medicines Reveals Q3 2025 Financials & Business Updates
    BeOne Medicines Reveals Q3 2025 Financials & Business Updates

    06 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251106844872/en/BeOne-Medicines-Announces-Third-Quarter-2025-Financial-Results-and-Business-Updates

    BUSINESSWIRE
    06 Nov 2025
    Share Share
    Insysbio To Announce Its Collaboration With Beone Medicines
    Insysbio To Announce Its Collaboration With Beone Medicines

    29 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/insysbio-to-announce-its-collaboration-with-beone-medicines-302595141.html

    PR NEWSWIRE
    29 Oct 2025
    Share Share
    Beone Medicines To Present At Upcoming Investor Conferences
    Beone Medicines To Present At Upcoming Investor Conferences

    28 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251028966834/en/BeOne-Medicines-to-Present-at-Upcoming-Investor-Conferences

    BUSINESSWIRE
    28 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search